S. Alverlind

Population pharmacokinetics of TC‐5214, a nicotinic channel modulator, in phase I and II clinical studies

S. Toler, Hongmei Xu, N. Al-Huniti, 2014, Journal of clinical pharmacology.

Clinical Pharmacokinetics of the Nicotinic Channel Modulator Dexmecamylamine (TC-5214) in Subjects with Various Degrees of Renal Impairment

S. Toler, H. Eriksson, R. Tummala, 2014, Clinical Drug Investigation.

Evaluation of the Effects of AZD3480 on Cardiac Repolarization: A Thorough QT/QTc Study Using Moxifloxacin as a Positive Control

H. Hårdemark, S. Alverlind, P. Dalén, 2010, Clinical pharmacology and therapeutics.

Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers

H. Hårdemark, S. Alverlind, G. Huledal, 2014, Clinical pharmacology in drug development.